Ken Griffin
RVPH

Ken Griffin’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Ken Griffin’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,732
Closed -$155K – 14072
2025
Q4 		$155K Buy
+27,732
New +$308K ﹤0.01% 11281
2025
Q2 		– Sell
-168
Closed -$2.62K – 14715
2025
Q1 		$3.2K Buy
+168
New +$5.28K ﹤0.01% 13982
2024
Q4 		– Sell
-675
Closed -$18.8K – 15260
2024
Q3 		$19.5K Buy
+675
New +$15K ﹤0.01% 12794
2024
Q1 		– Sell
-2,263
Closed -$179K – 15340
2023
Q4 		$233K Buy
2,263
+1,781
+370% +$160K ﹤0.01% 9646
2023
Q3 		$47K Sell
482
-3,679
-88% -$343K ﹤0.01% 11828
2023
Q2 		$488K Buy
4,161
+3,985
+2,264% +$505K ﹤0.01% 8000
2023
Q1 		$14.8K Buy
+176
New +$15.4K ﹤0.01% 13285
2022
Q4 		– Sell
-2,012
Closed -$153K – 15372
2022
Q3 		$64K Buy
+2,012
New +$55.6K ﹤0.01% 11450
2021
Q2 		– Sell
-1,833
Closed -$210K – 14315
2021
Q1 		$210K Buy
+1,833
New +$306K ﹤0.01% 11596

Other funds holding RVPH

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Ken Griffin's RVPH Position: Q1 2026 in Review

Ken Griffin sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q1 2026, closing a stake of 27,732 shares — an estimated $155K sold.

Ken Griffin first reported a position in RVPH in Q1 2021 and held it in 9 quarters. The position peaked at $488K in Q2 2023. 35 funds tracked by Wall St. Rank hold RVPH as of Q1 2026.

  • Ken Griffin reported no remaining REVIVA PHARMA HLDGS INC position as of Q1 2026 after selling out during the quarter.
  • Ken Griffin sold 27,732 REVIVA PHARMA HLDGS INC shares in Q1 2026, an estimated $155K.
  • Ken Griffin first reported a position in REVIVA PHARMA HLDGS INC in Q1 2021 and held it in 9 quarters.
  • Ken Griffin's REVIVA PHARMA HLDGS INC position peaked at $488K in Q2 2023.
  • 35 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.